Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Regulation Crypto Assets. Document Number: 2026-17183
Buy this Course
FR-26-2164-1
FDA Requirements for Prognostic Test Classification: Preeclampsia Risk Assessment
$9.99
Stay up to date with the latest FDA regulatory requirements affecting prognostic tests for preeclampsia. This course provides detailed guidance on compliance with the final rule classifying these tests as class II medical devices, including mandatory design, validation, labeling, and practitioner training steps. Learn what it takes to bring innovative preeclampsia risk assessment devices to market, minimize regulatory risk, and ensure product safety and effectiveness.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying the prognostic test for preeclampsia as class II.
* Identify the special controls and general controls applicable to this device type.
* Implement the required design, validation, labeling, and practitioner training measures.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this training, you may overlook essential FDA special controls and compliance steps, risking delays, costly rework, legal penalties, or denial of market access for your preeclampsia prognostic test.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Clinical Chemistry and Toxicology Devices; Classification of the Prognostic Test for Development or Progression of Preeclampsia.
Key regulatory references include:
Course SKU
FR-26-2038-1